Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Ann Thorac Surg. 2011 Sep;92(3):923–928. doi: 10.1016/j.athoracsur.2011.04.053

TABLE 1.

Recipient and Donor Demographics and Characteristics

Note that data for the re-transplant group is based on clinical characteristics at the time of re-transplant rather than the initial transplant.

Controls Re-transplant < 90
days
p-value
N 26,696 90
Recipient age (years) 51.9 ± 11.9 48.6 ± 12.8 0.004
Donor age (years) 31.2 ± 12.6 33.5 ± 13.1 0.96
Diabetic recipient 5,339 (20.0%) 14 (15.6%) 0.23
Underweight (BMI < 18.5) 952 (3.6%) 6 (6.7%) 0.10
Severely/Morbidly obese (BMI > 35) 1,009 (3.8%) 7 (7.8%) 0.04
Recipient eGFR (mL/min/m2) 52.5 ± 13.3 28.6 ± 25.3 <0.001
Total bilirubin >2 dl/mg 2,955 (11.1%) 33 (36.7%) < 0.001
Intubated 727 (2.7%) 53 (58.9%) < 0.001
Inotropic support 13,121 (49.1%) 71 (78.9%) < 0.001
Donor : Recipient weight <0.7 1,183 (4.4%) 4 (4.4%) 0.88
Transplant year 2001.3 ± 4.1 2001.1 ± 3.7 0.59
IABP 1402 (5.2%) 27 (30.0%) <0.001
ECMO 84 (0.3%) 14 (15.6%) < 0.001
LVAD 4,352 (16.3%) 33 (36.7%) < 0.001
RVAD 33 (0.1%) 2 (2.2%) <0.001
BiVAD 378 (1.4%) 5 (5.6%) 0.001

BiVAD: biventricular assist device, BMI: body mass index, ECMO: extracorporeal membrane oxygenation, eGFR: estimated glomerular filtration rate, IABP: intra-aortic balloon pump, LVAD: left ventricular assist device, MCS: mechanical circulatory support, RVAD: right ventricular assist device